Indo Us Bio-Tech (INDOUS.NS) Stock Price

Indo Us Bio-Tech Price

CLOSED
82.34INR-2.65 (-3.17 %)
Market closed

Over the last 11 years Indo Us Bio-Tech grew revenue by 19.4% annually, reaching 1.04 B INR. Earnings per share have grown at 28.1% per year over the last 11 years. For Indo Us Bio-Tech, the net margin of 15.7% is up versus 12.7% a few years ago. At today's price the dividend yield works out to roughly 0.30%. The payout ratio is around 6% of earnings.

Indo Us Bio-Tech stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Indo Us Bio-Tech over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Indo Us Bio-Tech stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Indo Us Bio-Tech's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Indo Us Bio-Tech Stock Price History
DateIndo Us Bio-Tech Price
8/3/202682.34 INR
7/30/202684.99 INR
7/28/202685.90 INR
7/24/202684.98 INR
7/23/202686.93 INR
7/22/202687.97 INR
7/20/202687.36 INR
7/17/202687.28 INR
7/16/202685.70 INR
7/15/202687.04 INR
7/14/202689.85 INR
7/13/202689.72 INR
7/10/202687.52 INR
7/9/202689.57 INR
7/8/202686.21 INR
7/7/202688.21 INR
7/3/202689.30 INR
7/2/202688.30 INR
7/1/202688.48 INR
6/30/202687.59 INR
6/29/202689.80 INR
6/25/202688.75 INR
6/24/202688.99 INR
6/23/202689.67 INR
6/22/202692.68 INR
6/19/202691.21 INR
6/18/202689.66 INR
6/17/202690.47 INR
6/16/202689.19 INR
6/15/202690.03 INR
6/12/202689.17 INR
6/11/202690.57 INR
6/10/202692.76 INR
6/9/202695.58 INR
6/8/202696.02 INR
6/5/202697.70 INR
6/4/202698.35 INR
6/3/202695.57 INR
6/2/202697.90 INR
6/1/202699.76 INR
5/29/202699.80 INR
5/28/2026100.58 INR
5/27/2026100.58 INR
5/26/202699.92 INR
5/25/2026100.61 INR
5/22/2026100.95 INR
5/21/2026101.67 INR
5/20/2026101.91 INR
5/19/2026101.79 INR
5/18/2026102.58 INR
5/15/2026105.23 INR
5/14/2026105.68 INR
5/13/2026106.08 INR
5/12/2026106.71 INR
5/11/2026109.09 INR
5/8/2026111.96 INR
5/7/2026112.58 INR
5/6/2026109.02 INR
5/5/2026104.04 INR
5/4/2026104.48 INR
4/30/2026104.27 INR
4/29/2026104.11 INR
4/28/2026101.84 INR
4/27/2026103.96 INR
4/24/2026102.51 INR
4/23/2026105.18 INR
4/22/2026106.86 INR
4/21/2026106.89 INR
4/20/2026106.78 INR
4/17/2026108.55 INR
4/16/2026109.91 INR
4/15/2026107.02 INR
4/13/2026106.29 INR
4/10/2026106.55 INR
4/9/2026106.96 INR
4/8/2026106.21 INR
4/7/2026108.97 INR
4/6/2026108.42 INR
4/2/2026104.92 INR
4/1/2026101.76 INR
3/30/202698.21 INR
3/27/2026100.99 INR
3/25/2026101.51 INR
3/24/2026102.49 INR
3/23/2026102.55 INR
3/20/2026104.19 INR
3/19/2026103.49 INR
3/18/2026106.63 INR
3/17/2026101.75 INR
3/16/202697.87 INR
3/13/2026100.01 INR
3/12/202699.67 INR
3/11/202699.85 INR
3/10/2026100.54 INR
3/9/2026102.45 INR
3/6/2026113.42 INR
3/5/2026138.10 INR
3/4/2026136.76 INR
3/2/2026140.71 INR
2/27/2026144.56 INR
2/26/2026141.43 INR
2/25/2026136.99 INR
2/24/2026145.44 INR
2/23/2026148.13 INR
2/20/2026150.72 INR
2/19/2026146.24 INR
2/18/2026149.80 INR
2/17/2026145.23 INR
2/16/2026134.39 INR
2/13/2026132.04 INR
2/12/2026126.83 INR
2/11/2026130.42 INR
2/10/2026130.08 INR
2/9/2026131.03 INR
2/6/2026125.95 INR
2/5/2026125.87 INR
2/4/2026125.91 INR
2/3/2026125.44 INR
2/2/2026125.20 INR
1/30/2026125.22 INR
1/29/2026131.46 INR
1/28/2026131.75 INR
1/27/2026125.00 INR
1/23/2026117.50 INR
1/22/2026111.98 INR
1/21/2026111.14 INR
1/20/2026108.46 INR
1/19/2026112.45 INR
1/16/2026114.77 INR
1/14/2026114.55 INR
1/13/2026118.91 INR
1/12/2026118.37 INR
1/9/2026114.53 INR
1/8/2026115.08 INR
1/7/2026119.45 INR
1/6/2026119.31 INR
1/5/2026119.24 INR
1/2/2026121.85 INR
1/1/2026120.50 INR
12/31/2025121.56 INR
12/30/2025122.67 INR
12/29/2025121.94 INR
12/26/2025123.59 INR
12/24/2025121.09 INR
12/23/2025121.75 INR
12/22/2025124.24 INR
12/19/2025123.34 INR
12/18/2025119.89 INR
12/17/2025123.58 INR
12/16/2025125.53 INR
12/15/2025126.25 INR
12/12/2025127.10 INR
12/11/2025126.29 INR
12/10/2025125.21 INR
12/9/2025128.14 INR
12/8/2025128.80 INR
12/5/2025128.54 INR
12/4/2025129.10 INR
12/3/2025131.65 INR
12/2/2025136.30 INR
12/1/2025125.95 INR
11/28/2025135.42 INR
11/27/2025147.09 INR
11/26/2025132.58 INR
11/25/2025110.49 INR
11/24/2025116.56 INR
11/21/2025122.73 INR
11/20/2025124.63 INR
11/19/2025124.49 INR
11/18/2025124.01 INR
11/17/2025124.58 INR
11/14/2025130.46 INR
11/13/2025130.38 INR
11/12/2025133.10 INR
11/11/2025134.19 INR
11/10/2025131.67 INR
11/7/2025132.87 INR
11/6/2025134.03 INR
11/4/2025135.52 INR
11/3/2025135.89 INR
10/31/2025134.31 INR
10/30/2025135.67 INR
10/29/2025142.24 INR
10/28/2025141.72 INR
10/27/2025134.42 INR
10/24/2025140.60 INR
10/23/2025140.24 INR
10/21/2025131.35 INR
10/20/2025120.48 INR
10/17/2025122.15 INR
10/16/2025125.22 INR
10/15/2025129.28 INR
10/14/2025129.86 INR
10/13/2025132.76 INR
10/10/2025134.32 INR
10/9/2025131.05 INR
10/8/2025132.41 INR
10/7/2025131.14 INR
10/6/2025130.73 INR
10/3/2025133.15 INR
10/1/2025137.57 INR
9/30/2025132.68 INR
9/29/2025135.60 INR
9/26/2025132.67 INR
9/25/2025140.10 INR
9/24/2025138.06 INR
9/23/2025139.53 INR
9/22/2025141.74 INR
9/19/2025143.04 INR
9/18/2025142.78 INR
9/17/2025143.05 INR
9/16/2025143.94 INR
9/15/2025143.61 INR
9/12/2025145.77 INR
9/11/2025148.32 INR
9/10/2025148.24 INR
9/9/2025145.67 INR
9/8/2025148.49 INR
9/5/2025147.92 INR
9/4/2025144.69 INR
9/3/2025145.70 INR
9/2/2025146.60 INR
9/1/2025149.57 INR
8/29/2025149.14 INR
8/28/2025149.11 INR
8/26/2025148.75 INR
8/25/2025149.71 INR
8/22/2025150.79 INR
8/21/2025150.82 INR
8/20/2025151.89 INR
8/19/2025155.05 INR
8/18/2025157.12 INR
8/14/2025157.36 INR
8/13/2025167.41 INR
8/12/2025168.85 INR
8/11/2025163.72 INR
8/8/2025170.27 INR
8/7/2025179.03 INR
8/6/2025179.35 INR
Access this data via the Eulerpool API
Get Free API Key

Indo Us Bio-Tech Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
294.43 M INR
25.53 M INR
14.49 M INR
Jan 1, 2019
353.48 M INR
32.16 M INR
20.88 M INR
Jan 1, 2020
397.61 M INR
37.48 M INR
25.35 M INR
Jan 1, 2021
400.87 M INR
52.61 M INR
50.98 M INR
Jan 1, 2022
500.59 M INR
63.04 M INR
50.63 M INR
Jan 1, 2023
617.45 M INR
85.50 M INR
72.40 M INR
Jan 1, 2024
728.36 M INR
99.95 M INR
82.51 M INR
Jan 1, 2025
1.04 B INR
178.37 M INR
162.67 M INR

Indo Us Bio-Tech Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 5, 2026, 8:46 PM
 
REVENUEB INR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM INR
EBITM INR
EBIT MARGIN%
NET INCOMEM INR
NET INCOME GROWTH%
DIV.INR
DIV. GROWTH%
SHARESM
201420152016201720182019202020212022202320242025
0.150.200.190.250.290.350.400.400.500.620.731.04
–31.76-2.5628.9520.0020.0712.460.7625.0023.4017.9942.58
15.5413.8511.0513.8821.4321.8119.9037.0027.6026.9032.1429.96
23.0027.0021.0034.0063.0077.0079.00148.00138.00166.00234.00311.00
2.005.007.0011.0025.0032.0037.0052.0063.0085.0099.00178.00
1.352.563.684.498.509.079.3213.0012.6013.7813.6017.15
2.004.002.003.0014.0020.0025.0050.0050.0072.0082.00162.00
–100.00-50.0050.00366.6742.8625.00100.00–44.0013.8997.56
–––––––0.250.42–0.250.50
––––––––68.00––100.00
4.904.855.835.834.115.6414.5614.5612.2419.2920.0820.03
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Indo Us Bio-Tech generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Indo Us Bio-Tech retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Indo Us Bio-Tech's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Indo Us Bio-Tech has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Indo Us Bio-Tech's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Indo Us Bio-Tech stock margins

The Indo Us Bio-Tech margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Indo Us Bio-Tech. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Indo Us Bio-Tech.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
21.55 %
8.67 %
4.92 %
Jan 1, 2019
21.97 %
9.10 %
5.91 %
Jan 1, 2020
19.93 %
9.43 %
6.37 %
Jan 1, 2021
37.01 %
13.12 %
12.72 %
Jan 1, 2022
27.76 %
12.59 %
10.11 %
Jan 1, 2023
26.93 %
13.85 %
11.73 %
Jan 1, 2024
32.22 %
13.72 %
11.33 %
Jan 1, 2025
30.03 %
17.18 %
15.67 %

Indo Us Bio-Tech Stock Revenue, EBIT, Earnings per Share

The Indo Us Bio-Tech earnings per share therefore indicates how much revenue Indo Us Bio-Tech has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
71.65 INR
6.21 INR
3.53 INR
Jan 1, 2019
62.70 INR
5.71 INR
3.70 INR
Jan 1, 2020
27.30 INR
2.57 INR
1.74 INR
Jan 1, 2021
27.53 INR
3.61 INR
3.50 INR
Jan 1, 2022
40.90 INR
5.15 INR
4.14 INR
Jan 1, 2023
32.01 INR
4.43 INR
3.75 INR
Jan 1, 2024
36.28 INR
4.98 INR
4.11 INR
Jan 1, 2025
51.83 INR
8.90 INR
8.12 INR

Indo Us Bio-Tech business model & stock analysis

Indo Us Bio-Tech Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Indo Us Bio-Tech historical P/E ratio, EBIT multiple, and P/S ratio

Indo Us Bio-Tech annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Indo Us Bio-Tech shares outstanding

The number of shares of Indo Us Bio-Tech was 20.03 M in 2025. This indicates how many shares Indo Us Bio-Tech is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
4.11 M Stocks
Jan 1, 2019
5.64 M Stocks
Jan 1, 2020
14.56 M Stocks
Jan 1, 2021
14.56 M Stocks
Jan 1, 2022
12.24 M Stocks
Jan 1, 2023
19.29 M Stocks
Jan 1, 2024
20.08 M Stocks
Jan 1, 2025
20.03 M Stocks

Indo Us Bio-Tech Dividend History

4 years of dividend payments

YearAnnual DividendYoY ChangePayments
20250.25INR 0.0%—
20240.25INR↑ 20.0%1×
20220.21INR↓ 16.7%—
20210.25INR—1×

Indo Us Bio-Tech dividend history and estimates

In 2025, Indo Us Bio-Tech paid a dividend amounting to 0.25 INR. Dividend means that Indo Us Bio-Tech distributes a portion of its profits to its owners.

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021 (e)
0.00 INR
0.25 INR
Jan 1, 2022 (e)
0.21 INR
0.21 INR
Jan 1, 2024 (e)
0.00 INR
0.25 INR
Jan 1, 2025 (e)
0.25 INR
0.25 INR

Indo Us Bio-Tech dividend payout ratio

In 2025, Indo Us Bio-Tech had a payout ratio of 6.04%. The payout ratio indicates the percentage of the company's profits that Indo Us Bio-Tech distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
6.02 %
Jan 1, 2019
6.02 %
Jan 1, 2020
6.02 %
Jan 1, 2021
5.95 %
Jan 1, 2022
6.02 %
Jan 1, 2023
6.02 %
Jan 1, 2024
6.08 %
Jan 1, 2025
6.04 %
Price targets and forecasts for Indo Us Bio-Tech are not yet available.

Indo Us Bio-Tech shareholder structure

% Name
48.82256%
Ajudia (Jagdishkumar Devjibhai)
Ajudia (Jagdishkumar Devjibhai)
10.70735%
Indous Agriseeds Pvt. Ltd.
Indous Agriseeds Pvt. Ltd.
5.73580%
Devjibhai (Ajudia Jagdish) HUF
Devjibhai (Ajudia Jagdish) HUF
2.91333%
Ajudia (Malti Jagdishbhai)
Ajudia (Malti Jagdishbhai)
1.99501%
Ajudia (Priyanka Jagdishbhai)
Ajudia (Priyanka Jagdishbhai)
1.99501%
Improwised Technologies Pvt Ltd
Improwised Technologies Pvt Ltd

Indo Us Bio-Tech Beneficial Ownership Filings (SEC 13D/G)

Free Float
23.5%
Float Shares
-
Shares Outstanding
-

Indo Us Bio-Tech Executives and Management Board

8 members · avg. age 42 · 88 % women

JA

Mr. Jagdish Ajudia (51)

Managing Director, Executive Director · since 2004

1.06 M INR

Management

DJ

Ms. Dimpy Joshi

Compliance Officer, Company Secretary

229,035.00 INR
RJ

Ms. Rinku Jethva

Chief Financial Officer

–

Board of Directors

MA

Mrs. Maltiben Ajudia

Wholetime Director

550,464.00 INR
PA

Ms. Priyanka Ajudia

Executive Director

210,299.00 INR
ST

Mrs. Shilpa Thumar (33)

Additional Independent Director

–
RK

Mrs. Ritaben Kikani

Non-Executive Independent Director

–
NP

Mrs. Neha Patel (43)

Non-Executive Independent Director

–

Frequently asked questions about Indo Us Bio-Tech

Converted at the current exchange rate, the Indo Us Bio-Tech share trades at 0.75 EUR (82.34 INR).

No history available for Indo Us Bio-Tech.

The revenue cannot currently be calculated for Indo Us Bio-Tech.

The profit cannot currently be calculated for Indo Us Bio-Tech.

The P/E ratio cannot be calculated for Indo Us Bio-Tech at the moment.

The P/S cannot be calculated for Indo Us Bio-Tech currently.

The Eulerpool Quality Score for Indo Us Bio-Tech is 7/10.

The ISIN of Indo Us Bio-Tech is INE250Z01010. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Indo Us Bio-Tech is INDOUS.NS. The ticker symbol is used to trade Indo Us Bio-Tech shares on the stock exchange.

Over the past 12 months, Indo Us Bio-Tech paid a dividend of 0.25 INR . This corresponds to a dividend yield of about 0.30 %. For the coming 12 months, Indo Us Bio-Tech is expected to pay a dividend of 0.25 INR.

The current dividend yield of Indo Us Bio-Tech is 0.30 %.

Indo Us Bio-Tech paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 0.25 INR are expected. This corresponds to a dividend yield of 0.30 %.

Indo Us Bio-Tech is assigned to the 'Non-cyclical consumption' sector.

To receive the latest dividend of Indo Us Bio-Tech from amounting to 0.25 INR, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

The dividends of Indo Us Bio-Tech are distributed in INR.

All fundamentals and in-depth analysis of Indo Us Bio-Tech

Our stock analysis for Indo Us Bio-Tech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Indo Us Bio-Tech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Indo Us Bio-Tech Stock
Indo Us Bio-Tech Revenue→
Indo Us Bio-Tech Stock
Indo Us Bio-Tech Net Income→
Indo Us Bio-Tech Stock
Indo Us Bio-Tech P/E→
Indo Us Bio-Tech Stock
Indo Us Bio-Tech P/S→
Indo Us Bio-Tech Stock
Indo Us Bio-Tech EBIT→
Indo Us Bio-Tech Stock
Indo Us Bio-Tech Dividend→
Indo Us Bio-Tech Stock
Indo Us Bio-Tech Directors Dealings→
Indo Us Bio-Tech Stock
Indo Us Bio-Tech Stocks→
Indo Us Bio-Tech Stock
Indo Us Bio-Tech Market capitalization→
Indo Us Bio-Tech Stock
Indo Us Bio-Tech Debt→
Indo Us Bio-Tech Stock
Indo Us Bio-Tech Liabilities→
Indo Us Bio-Tech Stock
Indo Us Bio-Tech Equity→
Indo Us Bio-Tech Stock
Indo Us Bio-Tech AAQS→
Indo Us Bio-Tech Stock
Indo Us Bio-Tech Employees→
Indo Us Bio-Tech Stock
Indo Us Bio-Tech ROE→
Indo Us Bio-Tech Stock
Indo Us Bio-Tech ROA→
Indo Us Bio-Tech Stock
Indo Us Bio-Tech ROCE→
Indo Us Bio-Tech Stock
Indo Us Bio-Tech News→
Indo Us Bio-Tech Stock
Indo Us Bio-Tech Analyst Price Targets→

Non-cyclical consumption Stocks

Indofood Agri ResourcesIndo Pureco Pratama Tbk PTIndofood CBP Sukses Makmur Tbk PTIndo Oil Perkasa Tbk PTIndofood Sukses Makmur Tbk PTIndian SucroseIndonesian Tobacco Tbk PTImuraya Group CoIndong Tea CompanyImperial BrandsIndustri Jamu dan Farmasi Sido Muncul Tbk PTImagenetixAll Stocks A–Z →